von Erkan Sahin | Dez. 9, 2024 | steroids
Semaglutide represents a significant advancement in the pharmacological treatment of type 2 diabetes and obesity. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it functions by mimicking the action of the natural incretin hormone GLP-1, which plays an...
